1[1]Kohler J, Dorso KL, Young K, et al. In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolate[J]. Antimicrob Agents Chemother, 1999,43:1170-1176
2[2]Friedland IR, Isaacs R, Mixson LA, et al. Use of surrogate antimicrobial agents to predict susceptibility to ertapenem[J]. Diagn Microbiol Infect Dis, 2002,43:61-64
3[3]Vetter N, Cambronero-Hernandez E, Rohlf J, et al. A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumonia[J]. Clin Ther,2002,24:1770-1785
4[4]Aldridge KE. Ertapenem (MK-0826), a new carbapenem: comparative in vitro activity against clinically significant anaerobes[J]. Diagn Microbiol Infect Dis, 2002,44:181-186
5[5]Fuchs PC, Barry AL, Brown SD. In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers[J]. Antimicrob Agents Chemother,2001,45 : 1915-1918
6[6]Livermore DM, Carter MW, Bagel S, et al. In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia[J]. Antimicrob Agents Chemother,2001,45:1860-1867
7[7]Goldstein EJ, Citron DM, Vreni Merriam C, et al. Comparative In vitro activities of ertapenem (MK-0826) against 1,001anaerobes isolated from human intra-abdominal infections[J].Antimicrob Agents Chemother, 2000,44: 2389-2394
8[8]Betriu C, Sanchez A, Palau ML, et al. In vitro activities of MK-0826 and 16 other antimicrobials against bacteroides fragilis group strains [J]. Antimicrob Agents Chemother, 2001,45;2372-2374
9[9]Cottagnoud P, Pfister M, Cottagnoud M, et al. Activities of ertapenem, a new long-acting carbapenem, against penicillinsensitive or -resistant pneumococci in experimental meningitis [J]. Antimicrob Agents Chemother, 2003,47 : 1943-1947
10[10]Livermore DM, Oakton KJ, Carter MW, et al. Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases[ J]. Antimicrob Agents Chemother, 2001,45 :2831-2837
